Shiyao Group Ouyi Pharmaceutical Co., Ltd. is a comprehensive large-scale enterprise mainly focusing on internationalization and industrialization of new products. It covers an area of ​​about 346 acres and has about 3,000 employees.

The company's production scope covers seven therapeutic areas, more than 400 preparation products and more than 20 chemical synthetic raw materials, and is equipped with internationally advanced "Bosch", "Fett", "Urman", "GEA", " IMA” and other automated production lines, with a comprehensive annual production capacity of 15 billion tablets of solid preparations and an annual production capacity of 1,500 tons of raw materials. The main preparation products include Xuanning, Olaining, Domesso, Keli, Abidol Hydrochloride Tablets, etc. ;The main raw materials include azithromycin, indomethacin, levamlodipine maleate, tramadol hydrochloride, imatinib methanesulfonate, etc.

Ouyi Pharmaceutical has established a complete three-level quality management system. All drug production lines have passed the new version of GMP certification. Three workshops have passed the "zero defect item" to pass the US FDA certification, and seven workshops have passed the official certification of WHO, Colombia, Peru, etc. A total of 3 CEP certificates and 4 DMF registration numbers were obtained; 10 varieties have entered the US market; 61 varieties, including azithromycin tablets, tramadol hydrochloride tablets, and 83 product specifications have passed the evaluation of the quality and efficacy consistency of generic drugs.

The company has established complete second-level and third-level R&D institutions, equipped with internationally advanced large-scale analytical instruments; has complete sets of equipment required for a complete small-scale, intermediate-level and amplified production of three-level R&D platforms; has 71 authorized invention patents, PCT International application; in recent years, the company's new products have been launched one after another, among which Oulaining, Xuanning, Ouyi, Weihong, Qingre Detox Soft Capsules, Gubang and other varieties have achieved good economic benefits, and Qingre Detox Soft Capsules It is listed as a protected variety of traditional Chinese medicine by the state.

The company has a sales network across the country. The market share of Ouyi, Vienna, Chimait, Gubang, Cefladine, Norfloxacin and other products ranks first among similar varieties in the country. The products are sold to Europe, Africa, Southeast Asia, and South America. As well as more than 100 countries and regions including Japan, it has now become a designated production enterprise for famous buyers in countries such as the Netherlands and Switzerland.

Looking to the future, Ouyi Pharmaceutical will adhere to the corporate mission of "making good medicine, serving China, and repaying the world with good rewards", practice the manufacturing concept of "strict, meticulous and fast, craftsmanship and intelligent manufacturing", and use more, newer and better quality. Products contribute to society!